 TELEDIAB-2 is a national, multicenter, controlled, randomised trial. The primary objective of the study is to show that during the initiation of a basal insulin treatment , a computerized decision-making system of adaptation of the insulin, coupled to a distance follow-up thanks to PDAphone or an interactive vocal server IVS, is able to improve metabolic control at the end of 4 mouths as compared with conventional care. 